v3.26.3
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue $ 14,575 $ 5,576 $ 27,083 $ 13,714
Costs and expenses        
Cost of revenue 5,478 2,705 11,361 6,949
Research and development 4,596 2,291 11,658 5,806
Selling, general, and administrative 1,707 575 3,365 1,674
Restructuring charges (credits) 3 278 (6) 472
Impairment 0 0 0 29
Total costs and expenses 11,784 5,849 26,378 14,930
Income (loss) from operations 2,791 (273) 705 (1,216)
Interest expense (related party of $351 and $— for the three months ended September 30, 2026 and 2025, respectively, and $864 and $— for the nine months ended September 30, 2026 and 2025, respectively) (675) (514) (1,968) (1,372)
Interest income 873 155 1,426 370
Other income (expense), net (related party of $561 and $- for the three months ended September 30, 2026 and 2025, respectively, and $561 and $- for the nine months ended September 30, 2026 and 2025, respectively) 1,025 140 (937) 342
Income (loss) before income taxes 4,014 (492) (774) (1,876)
Provision for (benefit from) income taxes (390) 562 (361) 714
Net income (loss) 4,404 (1,054) (413) (2,590)
Net income (loss) attributable to shareholders - basic 4,404 (1,054) (1,084) (2,590)
Net income (loss) attributable to shareholders - diluted $ 4,404 $ (1,054) $ (1,084) $ (2,590)
Net income (loss) per share of common stock attributable to common shareholders        
Basic (in USD per share) $ 0.37 $ (0.36) $ (0.15) $ (0.89)
Diluted (in USD per share) $ 0.35 $ (0.36) $ (0.15) $ (0.89)
Weighted average shares used in computing net income (loss) per share of common stock        
Basic (in shares) 11,942 2,941 7,274 2,915
Diluted (in shares) 12,475 2,941 7,274 2,915